We use cookies to give you the best possible online experience. If you continue, we'll assume you are happy for your web browser to receive all cookies from our website. See our cookie policy for more information on cookies and how to manage them.

Reduction due to significant falls across all major equity markets during the second half of 2008,
together with the continued fall in real estate capital values, leading to a reduction in average funds
under management for the period compared to the first half of 2008.

Net new business flows of £3 billion, with £2 billion of this from third party clients.

Underlying costs down by 9%

Underlying cost base, excluding foreign exchange and restructuring costs, reduced by 9% over the
last 12 months and ahead of our plan to deliver £500 million of cost savings by 2010.

Net asset value of 349 pence per share on an IFRS basis

Reduction in NAV to 349 pence for H1 2009 (FY 2008: 416 pence; H1 2008: 437 pence) impacted
by exchange movements of £1,476 million and pension schemes deficit increase of £1,380 million,
primarily driven by changes in discount rates and increases in long term inflation assumptions.

New business sales

Worldwide long-term new business sales, including investment products of £19,421 million 6%
down compared with H1 2008 (down 16% in local currency).

Life and pension sales down 4% to £17,473 million (down 15% in local currency) with higher sales
in North America more than offset by reductions across all regions.

Bancassurance remains a significant contributor, accounting for almost a third of our global life and
pensions sales. Sales through bancassurance channels were £5.4 billion for H1 2009.

Overall new business margin of 2.1%, in line with FY08 and a 0.2% increase on H1 2008.

IRR on life and pension new business for the group was 9.5% (H1 2008: 12.9%)

MCEV operating profit up 12% to £1,685 million

Life MCEV operating earnings up by 26% to £1,607 million.

Unfavourable movement in experience variance is driven predominately by adverse persistency
experience in a number of businesses.

Net asset value impacted by increase in pension schemes deficit of £1,380 million and unfavourable
exchange movements of £1,746 million.

Impact of marking own debt to market would add 67 pence to MCEV net asset value.

Increase in IGD solvency to £3.2 billion

Strong growth reflects a combination of operating and market performance as well as the benefit of
capital management initiatives.

Initiatives in the period include the issue of £0.2 billion of hybrid capital, issuance of hybrid debt in
the Netherlands of £0.4 billion and a £0.1 billion benefit from the disposal of the Dutch healthcare
business.

Sale of Australian life business for £452 million expected in Q3 2009, a return of 16 times 2008 IFRS
earnings. This transaction is expected to contribute around £0.4 billion to IGD surplus on completion.

US listing

Continued to make good progress on our global finance programme, which will bring with it
Sarbanes-Oxley compliance. This would enable us to consider a listing of our shares in the US if we
choose to do so. Over 20% of our shareholders are in the US.

Asset quality

Quality of Aviva's asset base continues to be strong.

No material deterioration since end 2008 in either credit quality or the proportion of assets which are
valued either based on quoted prices in an active market or using models with significant observable
market parameters.

94.8% of total debt securities are investment grade, with 1.6% below investment grade and 3.6%
not rated.

Total corporate debt defaults in H1 2009 of only £15 million and impairments of approximately £50
million (FY 2008: £140 million and £260 million).

UK commercial mortgage interest cover constant at 1.3 times.

No defaults recorded on bonds and commercial mortgages backing the UK annuity book.

Very limited exposure to RMBS (Sub prime, Alt A), ABS, wrapped credit, CDOs and CLOs; these
investments represent less than 1.0% of total balance sheet assets.